Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Stoke Therapeutics

- PMLiVE

Stoke Therapeutics appoints Thomas McCauley as Chief Scientific Officer

McCauley most recently served as the President and CEO of Neptune Bio

- PMLiVE

Biogen gains rights to Stoke’s Dravet syndrome candidate in deal worth $550m

The rare genetic epilepsy affects up to 38,000 people in the US, UK, EU and Japan

- PMLiVE

‘Missing protein’ biotech Stoke raises $142m in IPO

Continues pioneering research

‘Missing protein’ biotech Stoke raises $142m in IPO

Continues pioneering research

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links